122 related articles for article (PubMed ID: 84356)
1. Etiology and treatment of vasospasm following subarachnoid hemorrhage.
Nonaka T; Watanabe S; Chigasaki H; Miyaoka M; Ishii S
Neurol Med Chir (Tokyo); 1979 Jan; 19(1):53-60. PubMed ID: 84356
[No Abstract] [Full Text] [Related]
2. [Sequential ultrastructural changes of experimental cerebral vasospasm in dogs (author's transl)].
Kawasaki S
Neurol Med Chir (Tokyo); 1980 Mar; 20(3):237-45. PubMed ID: 6155633
[No Abstract] [Full Text] [Related]
3. Observations on the effects of intrathecal papaverine in experimental vasospasm.
Ogata M; Marshall BM; Lougheed WM
J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882
[No Abstract] [Full Text] [Related]
4. Cerebral vasospasm after subarachnoid hemorrhage.
Chyatte D; Sundt TM
Mayo Clin Proc; 1984 Jul; 59(7):498-505. PubMed ID: 6376963
[TBL] [Abstract][Full Text] [Related]
5. Corrugation of cerebral vessels following subarachnoid hemorrhage: comparison of two experimental models of chronic cerebral vasospasm.
Rickels E; Seifert V; Zumkeller M; Kunz U; Reale E
Exp Neurol; 1990 Feb; 107(2):178-86. PubMed ID: 2303126
[No Abstract] [Full Text] [Related]
6. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
Gavras H; Andrews P; Papadakis N
J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
[TBL] [Abstract][Full Text] [Related]
7. [Ultrastructural changes in cerebral arterial wall and cerebral vasopasm--an experimental study (author's transl)].
Tanabe Y; Kagawa Y; Takada M; Yamada H; Sakata K
No Shinkei Geka; 1978 Jul; 6(7):663-72. PubMed ID: 683448
[No Abstract] [Full Text] [Related]
8. [Presumative role of platelets in the development of prolonged cerebral vasospasm following subarachnoid hemorrhage].
Ye JM
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Jun; 20(3):157-9. PubMed ID: 3652850
[No Abstract] [Full Text] [Related]
9. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage.
Yamakawa K; Sasaki T; Tsubaki S; Nakagomi T; Saito I; Takakura K
Neurol Med Chir (Tokyo); 1991 Jan; 31(1):24-31. PubMed ID: 1712919
[TBL] [Abstract][Full Text] [Related]
10. Experimental cerebral vasospasm: resolution by chlorpromazine.
Blaumanis OR; Grady PA
Surg Neurol; 1982 Apr; 17(4):263-8. PubMed ID: 7079949
[TBL] [Abstract][Full Text] [Related]
11. The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value.
Peterson JW; Candia G; Spanos AJ; Zervas NT
Neurosurgery; 1989 Dec; 25(6):917-22. PubMed ID: 2601822
[TBL] [Abstract][Full Text] [Related]
12. Cerebral vasospasm following subarachnoid hemorrhage--experimental and clinical studies.
Ohmoto T; Yoshioka J; Shibata K; Morooka H; Matsumoto Y; Nishimoto A
Neurol Med Chir (Tokyo); 1979 Jan; 19(1):73-81. PubMed ID: 84358
[No Abstract] [Full Text] [Related]
13. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.
Seifert V; Stolke D; Kunz U; Resch K
Neurosurgery; 1988 Sep; 23(3):313-21. PubMed ID: 3147407
[TBL] [Abstract][Full Text] [Related]
14. Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report.
Kistler JP; Lees RS; Candia G; Zervas NT; Crowell RM; Ojemann RG
Stroke; 1979; 10(1):26-9. PubMed ID: 107621
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
[TBL] [Abstract][Full Text] [Related]
16. Alteration of experimental cerebral vasospasm by adrenergic blockade.
Flamm ES; Yasargil MG; Ransohoff J
J Neurosurg; 1972 Sep; 37(3):294-301. PubMed ID: 4403561
[No Abstract] [Full Text] [Related]
17. Intra-arterial nitroprusside treatment of acute experimental vasospasm.
Hirsh LF
Stroke; 1980; 11(6):601-5. PubMed ID: 7210065
[TBL] [Abstract][Full Text] [Related]
18. Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
Peterson EW; Searle R; Mandy FF; Leblanc R
J Neurosurg; 1973 Dec; 39(6):730-4. PubMed ID: 4357243
[No Abstract] [Full Text] [Related]
19. Cerebral vasospasm. Subarachnoid hemorrhage.
Fisher RG
J Kans Med Soc; 1974 Jan; 75(1):5-10. PubMed ID: 4405907
[No Abstract] [Full Text] [Related]
20. [Etiology and treatment of prolonged vasospasm --experimental and clinical studies-- (author's transl)].
Miyaoka M; Nonaka T; Watanabe H; Chigasaki H; Ishi S
Neurol Med Chir (Tokyo); 1976 Mar; 16(2 pt 2):103-14. PubMed ID: 62289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
